Terms: = Colorectal cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
206 results:
1. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience.
Manfrida S; Fionda B; Mariani S; Luca V; Bertolini R; Barbaro B; Chiloiro G; Frascino V; Tagliaferri L; Gambacorta MA
In Vivo; 2024; 38(3):1306-1315. PubMed ID: 38688632
[TBL] [Abstract] [Full Text] [Related]
2. An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Levy A; Morel D; Texier M; Sun R; Durand-Labrunie J; Rodriguez-Ruiz ME; Racadot S; Supiot S; Magné N; Cyrille S; Louvel G; Massard C; Verlingue L; Bouquet F; Bustillos A; Bouarroudj L; Quevrin C; Clémenson C; Mondini M; Meziani L; Tselikas L; Bahleda R; Hollebecque A; Deutsch E
Mol Cancer; 2024 Mar; 23(1):61. PubMed ID: 38519913
[TBL] [Abstract] [Full Text] [Related]
3. Metastases and treatment-resistant lineages in patient-derived cancer cells of colorectal cancer.
Fujino S; Miyoshi N; Ito A; Hayashi R; Yasui M; Matsuda C; Ohue M; Horie M; Yachida S; Koseki J; Shimamura T; Hata T; Ogino T; Takahashi H; Uemura M; Mizushima T; Doki Y; Eguchi H
Commun Biol; 2023 Nov; 6(1):1191. PubMed ID: 37996567
[TBL] [Abstract] [Full Text] [Related]
4. cancer Stem Cells Persist Despite Cellular Damage, Emergence of the Refractory Cell Population.
Nagae A; Miyoshi N; Fujino S; Horie M; Yachida S; Sasaki M; Sekido Y; Hata T; Hamabe A; Ogino T; Takahashi H; Uemura M; Yamamoto H; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Oct; 30(11):6913-6924. PubMed ID: 37523119
[TBL] [Abstract] [Full Text] [Related]
5. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug-resistant colon cancer stem cells and induced mitochondria-mediated cell death.
Manogaran P; Anandan A; Vijaya Padma V
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23395. PubMed ID: 37424111
[TBL] [Abstract] [Full Text] [Related]
6. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
[TBL] [Abstract] [Full Text] [Related]
7. Gradient-based Volumetric PET Parameters on Immediate Pre-ablation FDG-PET Predict Local Tumor Progression in Patients with colorectal Liver Metastasis Treated by Microwave Ablation.
Zirakchian Zadeh M; Yeh R; Kirov AS; Kunin HS; Gönen M; Sotirchos VS; Soares KS; Sofocleous CT
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):911-920. PubMed ID: 37268735
[TBL] [Abstract] [Full Text] [Related]
8. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
[TBL] [Abstract] [Full Text] [Related]
9. ALDH2 promotes cancer stemness and metastasis in colorectal cancer through activating β-catenin signaling.
Wei PL; Prince GMSH; Batzorig U; Huang CY; Chang YJ
J Cell Biochem; 2023 Jun; 124(6):907-920. PubMed ID: 37183314
[TBL] [Abstract] [Full Text] [Related]
10. Stemness targeting of colorectal cell lines mediated by BAMLET and 5-Flourouracil.
Babazadeh M; Zamani M; Mehrbod P; Mokarram P
Biochem Biophys Res Commun; 2023 Jul; 664():136-141. PubMed ID: 37167706
[TBL] [Abstract] [Full Text] [Related]
11. FAK downregulation suppresses stem-like properties and migration of human colorectal cancer cells.
Xu C; Zhang W; Liu C
PLoS One; 2023; 18(4):e0284871. PubMed ID: 37083591
[TBL] [Abstract] [Full Text] [Related]
12. Association of NRF2 with HIF-2α-induced cancer stem cell phenotypes in chronic hypoxic condition.
Hallis SP; Kim SK; Lee JH; Kwak MK
Redox Biol; 2023 Apr; 60():102632. PubMed ID: 36791645
[TBL] [Abstract] [Full Text] [Related]
13. Modulation of rectal cancer stemness, patient outcome and therapy response by adipokines.
Marques V; Ourô S; Afonso MB; Rodrigues CMP
J Physiol Biochem; 2023 May; 79(2):261-272. PubMed ID: 36495464
[TBL] [Abstract] [Full Text] [Related]
14. Abberant Immunohistochemical Expression of oct3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in colorectal Adenocarcinoma.
Busuioc C; Birla RD; Ultimescu F; Duţulescu S; Panaitescu E; Berindan-Neagoe I
Chirurgia (Bucur); 2022 Oct; 117(5):544-555. PubMed ID: 36318684
[No Abstract] [Full Text] [Related]
15. oct4 promoted proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in colon cancer cells by activating the SCF/c-Kit signaling pathway.
Bu X; Liu Y; Wang L; Yan Z; Xin G; Su W
Cell Cycle; 2023 Feb; 22(3):291-302. PubMed ID: 36258646
[TBL] [Abstract] [Full Text] [Related]
16. Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer.
Chen J; Wu Z; Zhang X; Liu Z; Wang Y; Shan F; Wang Y; Xia S; Zhang Y; Sun Y; Ji J; Li Z
Int J Colorectal Dis; 2022 Nov; 37(11):2321-2333. PubMed ID: 36243807
[TBL] [Abstract] [Full Text] [Related]
17. FK866 inhibits colorectal cancer metastasis by reducing NAD
Xie H; Lei Y; Mao Y; Lan J; Yang J; Quan H; Zhang T
Genes Genomics; 2022 Dec; 44(12):1531-1541. PubMed ID: 36214983
[TBL] [Abstract] [Full Text] [Related]
18. Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in colorectal cancer.
Bai L; Gao Z; Jiang A; Ren S; Wang B
Balkan Med J; 2022 Nov; 39(6):411-421. PubMed ID: 36172827
[TBL] [Abstract] [Full Text] [Related]
19. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer.
Lo YL; Lin HC; Tseng WH
Acta Biomater; 2022 Nov; 153():465-480. PubMed ID: 36115656
[TBL] [Abstract] [Full Text] [Related]
20. Transposon-activated pou5f1B promotes colorectal cancer growth and metastasis.
Simó-Riudalbas L; Offner S; Planet E; Duc J; Abrami L; Dind S; Coudray A; Coto-Llerena M; Ercan C; Piscuoglio S; Andersen CL; Bramsen JB; Trono D
Nat Commun; 2022 Aug; 13(1):4913. PubMed ID: 35987910
[TBL] [Abstract] [Full Text] [Related]
[Next]
